MAPK3 and diabetes mellitus: • Ang-(1–7) inhibits diabetes-induced transactivation of ErbB receptors in isolated MVB and opposes downstream signaling changes in ERK1/2, p38 MAPK, ROCK, eNOS, and lkB-α